
Neovasc NVCN
Quarterly report 2021-Q4
added 05-16-2026
Country |
|
IPO year |
- |
Industry |
Medical devices |
Stock Exchange |
NASDAQ CAPITAL |
Shares |
63 M |
Market Cap[1] |
$ 111 M |
EBITDA (LTM) |
$ -129 M |
P/E (LTM) |
- |
P/S (LTM) |
13.35 |
EPS (LTM) |
- |
Other stocks of industry "Medical devices"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
Cutera
CUTR
|
- | -10.19 % | $ 1.99 M | Nasdaq Global Select Market | ||
|
EDAP TMS S.A.
EDAP
|
- | - | $ 162 M | Nasdaq Global Market | ||
|
GenMark Diagnostics, Inc.
GNMK
|
- | - | $ 1.77 B | Nasdaq Global Select Market | ||
|
Avinger
AVGR
|
- | -20.74 % | $ 369 K | Nasdaq Capital Market | ||
|
Axonics Modulation Technologies
AXNX
|
- | - | $ 3.31 B | Nasdaq Global Select Market,SPB | ||
|
Eargo
EAR
|
- | - | $ 10.2 M | Nasdaq Global Select Market,SPB | ||
|
Lianluo Smart Limited
LLIT
|
- | 24.59 % | $ 44.8 M | Nasdaq Global Select Market | ||
|
Allied Healthcare Products
AHPI
|
- | 3.58 % | $ 2.21 M | Nasdaq Capital Market | ||
|
Obalon Therapeutics, Inc.
OBLN
|
- | -5.86 % | $ 30.6 M | Nasdaq Capital Market | ||
|
ClearPoint Neuro
CLPT
|
$ 13.35 | -0.67 % | $ 378 M | Nasdaq Capital Market | ||
|
Apollo Endosurgery
APEN
|
- | - | $ 475 M | Nasdaq Global Market | ||
|
Alphatec Holdings
ATEC
|
$ 8.24 | -0.42 % | $ 1.24 B | Nasdaq Global Select Market | ||
|
Aziyo Biologics
AZYO
|
- | 1.37 % | $ 20.5 M | Nasdaq Global Market | ||
|
BioSig Technologies
BSGM
|
- | 37.08 % | $ 85.7 M | Nasdaq Global Select Market | ||
|
BIOLASE
BIOL
|
- | -13.19 % | $ 166 K | Nasdaq Capital Market | ||
|
Conformis
CFMS
|
- | - | $ 16.4 M | Nasdaq Capital Market | ||
|
Cardiovascular Systems
CSII
|
- | 0.15 % | $ 844 M | Nasdaq Global Select Market,SPB | ||
|
IRIDEX Corporation
IRIX
|
$ 1.13 | 0.69 % | $ 19.1 M | Nasdaq Global Select Market | ||
|
Helius Medical Technologies
HSDT
|
$ 1.76 | 14.29 % | $ 38.8 M | Nasdaq Capital Market | ||
|
CryoLife, Inc.
CRY
|
- | -4.14 % | $ 702 M | NYSE,SPB | ||
|
CHF Solutions, Inc.
CHFS
|
- | 1.15 % | $ 34.5 M | Nasdaq Capital Market | ||
|
Cytosorbents Corporation
CTSO
|
$ 0.4 | 0.7 % | $ 24.9 M | Nasdaq Capital Market | ||
|
OrthoPediatrics Corp.
KIDS
|
$ 17.77 | -0.25 % | $ 417 M | Nasdaq Global Select Market,SPB | ||
|
Delcath Systems
DCTH
|
$ 11.96 | 2.05 % | $ 428 M | Nasdaq Capital Market | ||
|
Soliton, Inc.
SOLY
|
- | -1.42 % | $ 435 M | Nasdaq Global Select Market | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
- | -1.98 % | $ 98.3 M | Nasdaq Capital Market | ||
|
Itamar Medical Ltd.
ITMR
|
- | 0.03 % | $ 1.58 B | Nasdaq Global Select Market | ||
|
Misonix, Inc.
MSON
|
- | - | $ 462 M | Nasdaq Global Select Market | ||
|
LivaNova PLC
LIVN
|
$ 79.88 | 0.62 % | $ 4.36 B | Nasdaq Global Select Market | ||
|
LENSAR
LNSR
|
$ 5.77 | -0.86 % | $ 69 M | Nasdaq Capital Market | ||
|
Dynatronics Corporation
DYNT
|
- | 14.99 % | $ 929 K | Nasdaq Capital Market | ||
|
Pulmonx Corporation
LUNG
|
$ 1.33 | -3.28 % | $ 54.1 M | Nasdaq Global Select Market | ||
|
Electromed
ELMD
|
$ 37.76 | 1.67 % | $ 319 M | NYSE American | ||
|
MiMedx Group
MDXG
|
$ 3.69 | 2.36 % | $ 545 M | Nasdaq Global Select Market | ||
|
Butterfly Network
BFLY
|
$ 5.54 | - | $ 1.37 B | NYSE | ||
|
Intersect ENT, Inc.
XENT
|
- | - | $ 955 M | Nasdaq Global Market | ||
|
Second Sight Medical Products
EYES
|
- | -0.97 % | $ 54.4 M | Nasdaq Capital Market | ||
|
Myomo
MYO
|
$ 1.33 | 14.66 % | $ 55.7 M | NYSE American | ||
|
GBS
GBS
|
- | -0.57 % | $ 7.12 M | Nasdaq Global Market | ||
|
Orthofix Medical
OFIX
|
$ 9.32 | 0.11 % | $ 369 M | Nasdaq Global Select Market,SPB | ||
|
Globus Medical
GMED
|
$ 77.35 | -3.78 % | $ 10.5 B | NYSE,SPB | ||
|
Insulet Corporation
PODD
|
$ 148.66 | -0.7 % | $ 10.5 B | Nasdaq Global Select Market,SPB | ||
|
Profound Medical Corp.
PROF
|
$ 6.9 | 4.15 % | $ 209 M | Nasdaq Global Select Market | ||
|
CONMED Corporation
CNMD
|
$ 34.3 | -1.35 % | $ 1.06 B | NYSE,SPB | ||
|
Inspire Medical Systems
INSP
|
$ 40.9 | -4.22 % | $ 1.2 B | NYSE,SPB | ||
|
Integer Holdings Corporation
ITGR
|
$ 90.51 | -0.52 % | $ 3.14 B | NYSE,SPB | ||
|
Invacare Corporation
IVC
|
- | - | $ 24.7 M | NYSE | ||
|
Edwards Lifesciences Corporation
EW
|
$ 84.75 | -0.42 % | $ 49.6 B | NYSE,SPB | ||
|
Sintx Technologies
SINT
|
$ 2.18 | -0.46 % | $ 6.05 M | Nasdaq Capital Market |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.